Welcome to the UPF Digital Repository

Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial



Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

Thumbnail
Document Type: Article
Version: Published version
Date: 2024
This document is associated with a Creative Common license © 2024 Ferrata Storti Foundation Published under a CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Thumbnail

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking